Perbedaan Multi Hanna Kreasindo Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Multi Hanna Kreasindo Tbk. diperdagangkan di Rp137 (kapitalisasi pasar 510 M, volume 24 jam 7,95 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Multi Hanna Kreasindo Tbk. jauh lebih besar — sekitar 3× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Multi Hanna Kreasindo Tbk. lebih aktif diperdagangkan (7,95 jt vs 96,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MHKI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 510 M | 167,37 M |
Volume | 7,95 jt | 96,7 rb |
Lot | 79,48 rb | 967 |
Perputaran | 1,1 M | 23,82 jt |
Harga Rata-rata | 138,19 | 246,34 |
Nilai Transaksi | 1,1 M | 23,82 jt |
Harga Ekuilibrium Indikatif | 137 | 248 |
Volume Ekuilibrium Indikatif | 911 | 41 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Multi Hanna Kreasindo Tbk (Company), was established on September 23, 2004 based on Deed of Notary Drajat Dramaji, S.H., No.165. The company became effective commercially on September 23, 2004. The parent entity of the Company is PT Multi Hanna Sinergitama and the ultimate beneficial owners of the Company are Mr. Shahabuddin and Mr. Alwi.
Selengkapnya di halaman MHKI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →